Use when packaging AAAI code, data, multimedia appendices, technical appendices, reproducibility evidence, and post-acceptance artifact releases without violating double-blind or immutable-supplement rules.
日本語の概要は準備中です。原文の説明を表示しています。
Use when organizing AAAI supplementary material, including the technical appendix, multimedia appendix, and code/data ZIPs, while respecting that AAAI supplements are due with the paper, treated as immutable after submission, must stay double-blind, and should never hide main-paper-critical evidence from reviewers who skim the appendix.
インストールする前に、エージェントに与えられる指示の中身を確認できます。
Use this when deciding what belongs in the main paper, technical appendix, multimedia appendix, or code/data ZIP. AAAI supplementary material is due with the paper and should be treated as immutable once submitted unless current instructions say otherwise.
A broad-AI reviewer will skim the appendix, not study it, so placement decides whether evidence is actually seen. Anything a claim depends on belongs in the main paper; the appendix only deepens it.
| Material | Main paper | Technical appendix | Multimedia | Code/data ZIP |
|---|---|---|---|---|
| Core result | yes | no | no | no |
| Full proof | sketch | full | no | no |
| Extra ablation | summary | detail | no | no |
| Demo of behavior | no | no | yes | no |
| Scripts and configs | no | no | no | yes |
A vision paper hides its ablation table in the ZIP and leaves only a teaser figure in the paper. The navigation map exposes the gap: a disputed claim points to a file a skimming reviewer will miss. The fix moves the ablation summary into the main paper, keeps full per-class numbers in the technical appendix, and scrubs the ZIP's metadata so nothing deanonymizes the immutable supplement.
[Supplement plan] technical appendix / multimedia appendix / code-data ZIP / none
[Main-paper dependencies] <material that must not be hidden in supplement>
[Navigation map] <claim -> supplement file/section>
[Anonymity risks] <paths, metadata, links, ownership>
[Submission risk] <missing/corrupt/too large/not allowed>
まだレビューはありません。使ってみた感想をお寄せください。
概要と使いどころ
Use when packaging AAAI code, data, multimedia appendices, technical appendices, reproducibility evidence, and post-acceptance artifact releases without violating double-blind or immutable-supplement rules.
日本語の概要は準備中です。原文の説明を表示しています。
Use when drafting an AAAI author response (rebuttal) under the single short character-limited author-feedback window, the no-URL rule, no-new-results guidance, AI-generated-review handling, and the AAAI two-phase review process where Phase-2 papers receive one feedback round before SPC/AC discussion.
日本語の概要は準備中です。原文の説明を表示しています。
Use when preparing an accepted AAAI paper for camera-ready source submission to AAAI Press, including proceedings page limits, two-column template compliance, copyright transfer, purchased extra technical pages, deanonymization, registration, oral or poster presentation, and final public artifact release.
日本語の概要は準備中です。原文の説明を表示しています。
Use when designing or auditing AAAI experiments for the broad-AI program committee, including baselines, ablations, statistical significance, robustness, human evaluation, AI-for-Social-Impact and alignment/safety evidence, compute and cost reporting, and reproducibility-checklist alignment for Phase-1 survival.
日本語の概要は準備中です。原文の説明を表示しています。
Use when positioning an AAAI paper's novelty against archival work, contemporaneous arXiv or workshop papers, and AAAI/IJCAI/NeurIPS/ICML/ICLR neighbors across the broad AI scope, while staying inside AAAI's dual-submission and AI-as-source policy constraints and writing a related-work section legible to non-specialist reviewers.
日本語の概要は準備中です。原文の説明を表示しています。
Use when strengthening an AAAI paper's reproducibility checklist (placed after references), experimental traceability, seed and hyperparameter reporting, compute and cost disclosure, dataset access and licensing, code/data ZIP readiness, and the claim-to-evidence map that Phase-1 reviewers use to judge rigor across AAAI's broad AI scope.
日本語の概要は準備中です。原文の説明を表示しています。